![Michael Woudenberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 $ al 31/07/2026
Michael Woudenberg is currently the Chief Operating Officer at InMed Pharmaceuticals, Inc., a position held since 2022.
Formerly, Mr. Woudenberg was the Managing Director at Phyton Biotech LLC.
Mr. Woudenberg completed undergraduate studies at the University of Western Ontario.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/12/2025 | 1 ( 0 % ) | 1 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INMED PHARMACEUTICALS INC. | Director de Operaciones | 15/07/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
Phyton Biotech LLC
 Phyton Biotech LLC BiotechnologyHealth Technology Develops plant molecules | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
InMed Pharmaceuticals, Inc.
 InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Phyton Biotech LLC
Phyton Biotech LLC BiotechnologyHealth Technology Develops plant molecules | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
